The UK government’s new life sciences plan has been met with skepticism by the pharmaceutical industry, which says the ...

The US regulator has launched a new national initiative to help Medicaid programs fund gene therapies for sickle cell disease ...

On Tuesday, the day new global data reveal that childhood vaccine coverage has stalled and deadly disease outbreaks are ...

Sino Biopharmaceutical (HKEX: 1177) is acquiring the remaining stake in Chinese biotech LaNova Medicines, setting the stage ...

The US Food and Drug Administration approved, the first rapid-acting interchangeable biosimilar product, Kirsty (insulin ...

China-based Jiangsu Hengrui Pharma and US start-up Kailera Therapeutics, which is advancing a broad pipeline of ...

The USA's Institute for Clinical and Economic Review (ICER) has released a Final Evidence Report assessing the comparative ...

Russia will begin commercial production of a new anticancer vaccine, which massive supplies for the needs of domestic ...

US biotech Tract Bio has appointed Chris Galloway as chief medical and development officer, as it prepares for an ...

The Bristol Myers Squibb subsidiary RayzeBio has opened a new 77,000-square-foot facility in Indianapolis, Indiana.

In the USA, the 340B hospital markup program cost state and federal taxpayers an estimated $6.5 billion per year due to lost ...

If approved, MCO-010 would be the first treatment to restore vision in legally blind RP patients without needing genetic ...